Incidence and costs of adverse drug reactions during hospitalisation - Computerised monitoring versus stimulated spontaneous reporting

H. Dormann et al., Incidence and costs of adverse drug reactions during hospitalisation - Computerised monitoring versus stimulated spontaneous reporting, DRUG SAFETY, 22(2), 2000, pp. 161-168
Citations number
Categorie Soggetti
Journal title
ISSN journal
0114-5916 → ACNP
Year of publication
161 - 168
SICI code
Objective: To implement a computer-based adverse drug reaction monitoring s ystem and compare its results with those of stimulated spontaneous reportin g, and to assess the excess lengths of stay and costs of patients with veri fied adverse drug reactions. Design: A prospective cohort study was used to assess the efficacy of compu ter-based monitoring, and case-matching was used to assess excess length of stay and costs. Setting: This was a study of all patients admitted to a medical ward of a u niversity hospital in Germany between June and December 1997. Patients and participants: 379 patients were included, most of whom had inf ectious, gastrointestinal or liver diseases, or sleep apnoea syndrome. Pati ents admitted because of adverse drug reactions were excluded. Methods: All automatically generated laboratory signals and reports were ev aluated by a team consisting of a clinical pharmacologist, a clinician and a pharmacist for their likelihood of being an adverse drug reaction. They w ere classified by severity and causality. For verified adverse drug reactio ns, control patients with similar primary diagnosis, age, gender and time o f admission but without adverse drug reactions were matched to the cases in order to assess the excess length of hospitalisation caused by an adverse drug reaction. Results: Adverse drug reactions were detected in 12% of patients by the com puter-based monitoring system and stimulated spontaneous reporting together (46 adverse reactions in 45 patients) during 1718 treatment days. Computer -based monitoring identified adverse drug reactions in 34 cases, and stimul ated spontaneous reporting in 17 cases. Only 5 adverse drug reactions were detected by both methods. The relative sensitivity of computer-based monito ring was 74% (relative specificity 75%), and that of stimulated spontaneous reporting was 37% (relative specificity 98%). All 3 serious adverse drug r eactions were detected by computer-based monitoring, but only 2 out of the 3 were detected by stimulated spontaneous reporting. Thr percentage of auto matically generated laboratory signals associated with an adverse drug reac tion (positive predictive value) was 13%. The mean excess length of stay wa s 3.5 days per adverse drug reaction. 48% of adverse reactions were predict able and detected solely by computer-based monitoring. Therefore, the poten tial for savings on this ward from the introduction of computer-based monit oring can be calculated as EUR56 200/year ($US59 600/year) [1999 values]. Conclusion: Computer monitoring is an effective method for improving the de tection of adverse drug reactions in inpatients. The excess length of stay and costs caused by adverse drug reactions are substantial and might be con siderably reduced by earlier detection.